American Heart Journal
Volume 152, Issue 3 , Pages 448.e1-448.e7 , September 2006

Rationale and design of the Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT) trial

  • Andrew G. Bostom, MD, MS

      Affiliations

    • Rhode Island Hospital, Providence, RI
    • ,
  • Myra A. Carpenter, PhD

      Affiliations

    • Departments of Epidemiology and Biostatistics, University of North Carolina School of Public Health, Chapel Hill, NC
    • ,
  • John W. Kusek, PhD

      Affiliations

    • Division of Kidney, Urology and Hematologic Diseases, National Institute of Diabetes and Digestive and Kidney Disease, National Institutes of Health, Bethesda, MD
    • ,
  • Lawrence G. Hunsicker, MD

      Affiliations

    • University of Iowa, Iowa City, IA
    • ,
  • Marc A. Pfeffer, MD, PhD

      Affiliations

    • Brigham and Women's Hospital, Boston, MA
    • ,
  • Andrew S. Levey, MD

      Affiliations

    • New England Medical Center, Boston, MA
    • Corresponding Author InformationReprint requests: Andrew G. Bostom, MD, Rhode Island Hospital, 593 Eddy Street, POB 242, Providence, RI 02903.
    • ,
  • Paul F. Jacques, ScD

      Affiliations

    • Jean Mayer USDA Human Nutrition Research Center on Aging, Boston, MA
    • ,
  • Joyce McKenney, MA, MPH

      Affiliations

    • Rhode Island Hospital, Providence, RI
    • ,
  • for the FAVORIT Investigators

Received 7 December 2005 ,Accepted 7 March 2006.

References 

  1. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998;32(5 Suppl 3):S112–S119
  2. Levey AS, Beto JA, Coronado BE, et al. Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. Am J Kidney Dis. 1998;32:853–906
  3. Shlipak MG, Fried LF, Cushman M, et al. Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors. JAMA. 2005;293:1737–1745
  4. Bostom AG, Culleton BF. Hyperhomocysteinemia in chronic renal disease. J Am Soc Nephrol. 1999;10:891–900
  5. Linnell JC, Bhatt HR. Inherited errors of cobalamin metabolism and their management. Baillieres Clin Haematol. 1995;8:567–601
  6. Mudd SH, Levy HL, Skovby F. Disorders of transsulfuration. In:  Scriver CR,  Beaudet AL editor. Metabolic basis of inherited disease. 6th ed. New York: McGraw Hill, Inc; 1989;
  7. Rosenblatt DS. Inherited disorders of folate transport and metabolism. In:  Scriver CR,  Beaudet AL,  Sly WS, et al. editor. Metabolic basis of inherited disease. 6th ed.. New York: McGraw Hill, Inc.; 1989;p. 2049–2064
  8. Mudd SH, Skovby F, Levy HL, et al. The natural history of homocystinuria due to cystathionine beta-synthase deficiency. Am J Hum Genet. 1985;37:1–31
  9. Wilcken DE, Wilcken B. The natural history of vascular disease in homocystinuria and the effects of treatment. J Inherit Metab Dis. 1997;20:295–300
  10. Ueland PM, Refsum H, Stabler SP, et al. Total homocysteine in plasma or serum: methods and clinical applications. Clin Chem. 1993;39:1764–1779
  11. Ueland PM, Refsum H, Beresford SA, et al. The controversy over homocysteine and cardiovascular risk. Am J Clin Nutr. 2000;72:324–332
  12. Clarke R. Homocysteine-lowering trials for prevention of heart disease and stroke. Semin Vasc Med. 2005;5:215–222
  13. Jacques PF, Selhub J, Bostom AG, et al. The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med. 1999;340:1449–1454
  14. Massy ZA, Chadefaux-Vekemans B, Chevalier A, et al. Hyperhomocysteinaemia: a significant risk factor for cardiovascular disease in renal transplant recipients. Nephrol Dial Transplant. 1994;9:1103–1108
  15. Bostom AG, Shemin D, Verhoef P, et al. Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients. A prospective study. Arterioscler Thromb Vasc Biol. 1997;17:2554–2558
  16. Ducloux D, Motte G, Challier B, et al. Serum total homocysteine and cardiovascular disease occurrence in chronic, stable renal transplant recipients: a prospective study. J Am Soc Nephrol. 2000;11:134–137
  17. Jungers P, Chauveau P, Bandin O, et al. Hyperhomocysteinemia is associated with atherosclerotic occlusive arterial accidents in predialysis chronic renal failure patients. Miner Electrolyte Metab. 1997;23:170–173
  18. Moustapha A, Naso A, Nahlawi M, et al. Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease. Circulation. 1998;97:138–141
  19. Winkelmayer WC, Kramar R, Curhan GC, et al. Fasting plasma total homocysteine levels and mortality and allograft loss in kidney transplant recipients: a prospective study. J Am Soc Nephrol. 2005;16:255–260
  20. Bostom AG, Gohh RY, Liaugaudas G, et al. Prevalence of mild fasting hyperhomocysteinemia in renal transplant versus coronary artery disease patients after fortification of cereal grain flour with folic acid. Atherosclerosis. 1999;145:221–224
  21. Beaulieu AJ, Gohh RY, Han H, et al. Enhanced reduction of fasting total homocysteine levels with supraphysiological versus standard multivitamin dose folic acid supplementation in renal transplant recipients. Arterioscler Thromb Vasc Biol. 1999;19:2918–2921
  22. Bostom AG, Gohh RY, Beaulieu AJ, et al. Treatment of hyperhomocysteinemia in renal transplant recipients. A randomized, placebo-controlled trial. Ann Intern Med. 1997;127:1089–1092
  23. Bostom AG, Shemin D, Gohh RY, et al. Treatment of mild hyperhomocysteinemia in renal transplant recipients versus hemodialysis patients. Transplantation. 2000;69:2128–2131
  24. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31–41
  25. Piantadosi S. Clinical trials: a methodologic perspective. New York: Wiley; 1997;
  26. Herzog C. The USRDS and its products. United States Renal Data System. Am J Kidney Dis. 1997;30(2 Suppl 1):S21–S39
  27. Elashoff JD, nQuery Advisor Version 4.0 User's Guide 2000. Los Angeles: Karger Publishers
  28. Lan KKG, DeMets DL. Discrete sequential boundaries for clinical trials. Biometrika. 1983;70:659–663
  29. Halperin M, Lan KK, Ware JH, et al. An aid to data monitoring in long-term clinical trials. Control Clin Trials. 1982;3:311–323
  30. SAS Institute . SAS language reference: concepts, version 8. Cary (NC): SAS Institute Inc.; 1999;
  31. Baker F, Picton D, Blackwood S, et al. Blinded comparison of folic acid and placebo in patients with ischemic heart disease: an outcome trial. Circulation. 2002;106:II-741
  32. Bonaa KH. NORVIT: randomised trial of homocysteine-lowering with B-vitamins for secondary prevention of cardiovascular disease after acute myocardial infarction. In: European Society of Cardiology Congress. Stockholm, Sweden. 2005;
  33. Toole JF, Malinow MR, Chambless LE, et al. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA. 2004;291:565–575
  34. Wrone EM, Hornberger JM, Zehnder JL, et al. Randomized trial of folic acid for prevention of cardiovascular events in end-stage renal disease. J Am Soc Nephrol. 2004;15:420–426
  35. Bostom AG, Shemin D, Gohh RY, et al. Treatment of hyperhomocysteinemia in hemodialysis patients and renal transplant recipients. Kidney Int Suppl. 2001;78:S246–S252

 A list of the FAVORIT Investigators can be found in Appendix A. Members of the Data and Safety Monitoring Board are listed in Appendix B.

 This research was supported by cooperative agreement U01 DK61700-01 from the National Institute of Diabetes and Digestive and Kidney Diseases and additional financial support from the Office of Dietary Supplements, National Institutes of Health, Department of Health and Human Services. Vitamins were provided by Pamlab, L.L.C.

PII: S0002-8703(06)00229-8

doi: 10.1016/j.ahj.2006.03.004

American Heart Journal
Volume 152, Issue 3 , Pages 448.e1-448.e7 , September 2006

Article Tools